Calmaxid
Calmaxid Brand names, Calmaxid Analogs
Calmaxid Brand Names Mixture
- No information avaliable
Calmaxid Chemical_Formula
C12H21N5O2S2
Calmaxid RX_link
http://www.rxlist.com/cgi/generic/nizat.htm
Calmaxid fda sheet
Calmaxid msds (material safety sheet)
Calmaxid Synthesis Reference
R. P. Pioch, U.S. Pat. 4,375,547 (1982)
Calmaxid Molecular Weight
331.46 g/mol
Calmaxid Melting Point
203 oC
Calmaxid H2O Solubility
10-33mg/mL
Calmaxid State
Solid
Calmaxid LogP
1.506
Calmaxid Dosage Forms
Capsule (150, 300 mg)
Calmaxid Indication
For the treatment of acid-reflux disorders (GERD), peptic ulcer disease, active benign gastric ulcer, and active duodenal ulcer.
Calmaxid Pharmacology
Nizatidine is a competitive, reversible inhibitor of histamine at the histamine H2-receptors, particularly those in the gastric parietal cells. By inhibiting the action of histamine on stomach cells, nizatidine reduces stomach acid production. Nizatidine had no demonstrable antiandrogenic action. Full-dose therapy for the problems treated by nizatidine lasts no longer than 8 weeks. It has been demonstrated that treatment with a reduced dose of nizatidine is effective as maintenance therapy following healing of active duodenal ulcers.
Calmaxid Absorption
Rapid (bioavailability of nizatidine exceeds 70%)
Calmaxid side effects and Toxicity
Oral, rat LD50: 301 mg/kg. Symptoms of overdose include cholinergic-type effects including lacrimation, salivation, emesis, miosis, and diarrhea.
Calmaxid Patient Information
Calmaxid Organisms Affected
Humans and other mammals
